US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Niagen Bioscience

2.69

+0.03001.13%

Post-market: 2.690.00000.00%19:30 EDT

Volume:268.12K

Turnover:719.65K

Market Cap:214.24M

PE:14.15

High:2.71

Open:2.68

Low:2.67

Close:2.66

52wk High:7.95

52wk Low:2.61

Shares:79.64M

Float Shares:55.82M

Volume Ratio:0.35

T/O Rate:0.48%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.1901

EPS(LYR):0.2000

ROE:21.80%

ROA:5.44%

PB:2.60

PE(LYR):13.45

Loading ...

Overview Company News Filings

Niagen Bioscience Earnings Call Highlights Growth Push

Promising Penny Stocks To Consider In May 2026

Simply Wall St.

May 2026's Promising Penny Stocks

Simply Wall St.

Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks

Simply Wall St.

Creative Global Technology Holdings And 2 Other Promising Penny Stocks

Simply Wall St.

Niagen Bioscience Is Maintained at Buy by HC Wainwright & Co.

Niagen Bioscience to attend Sohn Investment Conference Emerging Company Pavilion

The Benchmark Company Announces 4th Annual Consumer One-on-One Conference in New York City

Niagen Bioscience price target lowered to $12 from $13 at Roth Capital

Niagen Bioscience posts investor deck outlining NAD+ healthy-aging strategy

Niagen Bioscience Inc reports results for the quarter ended March 31 - Earnings Summary

Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs

Benzinga Earnings

BRIEF-Niagen Bioscience Inc Q1 Sales USD 31.474 Million Vs. IBES Estimate USD 30.9 Million

Niagen Bioscience Inc Outlook FY Revenue Growth 10-15%

THOMSON REUTERS

Niagen Bioscience Inc Q1 EPS USD 0.07 VS. Ibes Estimate USD 0.07

THOMSON REUTERS

Press Release: Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results

Niagen Bioscience Is Maintained at Buy by Canaccord Genuity

Niagen Bioscience Inc expected to post earnings of 8 cents a share - Earnings Preview

BRIEF-Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering

3 Promising Penny Stocks With Market Caps Under $200M

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NAGE/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":2.69,"timestamp":1791576000000,"preClose":2.66,"halted":0,"volume":268123,"hourTrading":{"tag":"盘后","latestPrice":2.69,"preClose":2.69,"latestTime":"19:30 EDT","volume":853,"amount":2294.57,"timestamp":1791588604287,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.011278195488721731,"floatShares":55819168,"shares":79644327,"eps":0.190148,"marketStatus":"Market Closed","change":0.03,"latestTime":"10-09 16:00:00 EDT","open":2.68,"high":2.71,"low":2.665,"amount":719653.7149136,"amplitude":0.016917,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.190148,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.66,"preHourTrading":{"tag":"盘前","latestPrice":2.67,"preClose":2.66,"latestTime":"08:06 EDT","volume":1,"amount":2.67,"timestamp":1791547566336,"change":0.01,"changeRate":0.003759,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.69,"preClose":2.69,"latestTime":"19:30 EDT","volume":853,"amount":2294.57,"timestamp":1791588604287,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.35236372276081795,"impliedVol":1.1866,"impliedVolPercentile":0.4223},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","floatShares":55819168,"roa":"5.44%","roe":"21.80%","lyrEps":0.2,"volumeRatio":0.35236372276081795,"shares":79644327,"dividePrice":0,"high":2.71,"amplitude":0.016917,"preClose":2.66,"low":2.665,"week52Low":2.61,"pbRate":"2.60","psRate":"1.66","week52High":7.95,"institutionHeld":0,"latestPrice":2.69,"eps":0.190148,"divideRate":0,"volume":268123,"delay":0,"ttmEps":0.190148,"open":2.68,"prevYearClose":6.36,"prevWeekClose":2.79,"prevMonthClose":2.92,"prevQuarterClose":2.92,"fiveDayClose":2.79,"twentyDayClose":3.04,"sixtyDayClose":3.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"NAGE","fiscalQuarterEnding":"2026/06","expectedEps":0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":0.01},{"market":"US","date":"2026-05-06","symbol":"NAGE","fiscalQuarterEnding":"2026/03","expectedEps":0.06,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2026-03-04","symbol":"NAGE","fiscalQuarterEnding":"2025/12","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"post","actualEps":0.03},{"market":"US","date":"2025-11-04","symbol":"NAGE","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.05},{"market":"US","date":"2025-08-06","symbol":"NAGE","fiscalQuarterEnding":"2025/06","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1783396800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAGE","date":"2026-10-09","current":14.146875,"percent":0,"low":13.189881,"twenty":15.520424,"median":25.482373,"eighty":54.228731,"high":80.643552,"avg":33.827972,"sd":19.71727,"marketCap":210919385},"quantilePoints":[{"date":"2025-03-21","current":69.624479,"twenty":69.806742,"median":70.080136,"eighty":70.353531,"marketCap":595289295},{"date":"2025-03-28","current":67.346191,"twenty":68.676711,"median":69.624479,"eighty":70.371757,"marketCap":575809933},{"date":"2025-04-04","current":60.420196,"twenty":62.662031,"median":67.938546,"eighty":69.697384,"marketCap":516592673},{"date":"2025-04-11","current":51.67157,"twenty":54.861173,"median":62.880747,"eighty":69.551574,"marketCap":441791924},{"date":"2025-04-17","current":59.600012,"twenty":54.815607,"median":61.696037,"eighty":69.259953,"marketCap":509580103},{"date":"2025-04-25","current":67.255059,"twenty":55.043436,"median":62.151694,"eighty":68.530901,"marketCap":575030758},{"date":"2025-05-02","current":68.895427,"twenty":55.954751,"median":62.880747,"eighty":69.442216,"marketCap":589055899},{"date":"2025-05-09","current":51.710369,"twenty":55.954751,"median":65.022337,"eighty":70.535794,"marketCap":729374756},{"date":"2025-05-16","current":58.761783,"twenty":54.815607,"median":62.789615,"eighty":69.71561,"marketCap":828834951},{"date":"2025-05-23","current":56.859021,"twenty":55.043436,"median":61.650471,"eighty":69.624479,"marketCap":801996485},{"date":"2025-05-30","current":60.552618,"twenty":55.242319,"median":61.364091,"eighty":69.478669,"marketCap":854094682},{"date":"2025-06-06","current":64.414107,"twenty":55.822209,"median":61.604905,"eighty":69.296406,"marketCap":908560979},{"date":"2025-06-13","current":79.132535,"twenty":56.409541,"median":62.698483,"eighty":70.55402,"marketCap":1116164400},{"date":"2025-06-20","current":77.117845,"twenty":56.623974,"median":63.647427,"eighty":71.912091,"marketCap":1087747202},{"date":"2025-06-27","current":77.341699,"twenty":56.791865,"median":65.523561,"eighty":75.181504,"marketCap":1090904668},{"date":"2025-07-03","current":71.129739,"twenty":57.426855,"median":65.645306,"eighty":75.483707,"marketCap":1003284974},{"date":"2025-07-11","current":65.981088,"twenty":58.471876,"median":66.48476,"eighty":75.192697,"marketCap":930663244},{"date":"2025-07-18","current":57.950311,"twenty":58.471876,"median":65.645306,"eighty":75.114348,"marketCap":817389135},{"date":"2025-07-25","current":51.87826,"twenty":56.758286,"median":65.022337,"eighty":74.190401,"marketCap":731742856},{"date":"2025-08-01","current":52.325969,"twenty":55.224884,"median":64.358143,"eighty":72.732275,"marketCap":738057789},{"date":"2025-08-08","current":43.320593,"twenty":54.318273,"median":62.947882,"eighty":72.15947,"marketCap":768030786},{"date":"2025-08-15","current":43.771379,"twenty":53.985743,"median":62.607352,"eighty":71.628921,"marketCap":776022782},{"date":"2025-08-22","current":44.041851,"twenty":52.415511,"median":61.650471,"eighty":71.37484,"marketCap":780817979},{"date":"2025-08-29","current":44.267244,"twenty":51.68709,"median":61.280145,"eighty":71.129739,"marketCap":784813977},{"date":"2025-09-05","current":42.013311,"twenty":50.71606,"median":60.552618,"eighty":71.083855,"marketCap":744853999},{"date":"2025-09-12","current":43.365671,"twenty":45.745824,"median":60.318517,"eighty":70.845641,"marketCap":768829986},{"date":"2025-09-19","current":45.709762,"twenty":45.222912,"median":59.50888,"eighty":70.6087,"marketCap":810388363},{"date":"2025-09-26","current":42.419019,"twenty":45.024566,"median":58.520194,"eighty":70.371757,"marketCap":752046795},{"date":"2025-10-03","current":33.268051,"twenty":44.46559,"median":56.887002,"eighty":69.697384,"marketCap":589809282},{"date":"2025-10-10","current":34.079467,"twenty":44.02382,"median":56.607185,"eighty":69.623328,"marketCap":604194874},{"date":"2025-10-17","current":33.448366,"twenty":43.66319,"median":55.29204,"eighty":69.583421,"marketCap":593006080},{"date":"2025-10-24","current":33.448366,"twenty":43.41075,"median":54.929521,"eighty":69.405763,"marketCap":593006080},{"date":"2025-10-31","current":32.050928,"twenty":43.28453,"median":54.228731,"eighty":69.187048,"marketCap":568230894},{"date":"2025-11-07","current":25.87441,"twenty":42.455082,"median":54.050915,"eighty":68.822522,"marketCap":528588317},{"date":"2025-11-14","current":27.403352,"twenty":42.022327,"median":53.333314,"eighty":68.390298,"marketCap":559823081},{"date":"2025-11-21","current":26.30565,"twenty":34.151593,"median":52.437896,"eighty":67.731548,"marketCap":537398122},{"date":"2025-11-28","current":26.540872,"twenty":33.854074,"median":52.018169,"eighty":67.346191,"marketCap":542203471},{"date":"2025-12-05","current":26.266446,"twenty":33.628681,"median":51.67157,"eighty":67.255059,"marketCap":536597231},{"date":"2025-12-12","current":25.992021,"twenty":33.448366,"median":50.903505,"eighty":67.255059,"marketCap":530990991},{"date":"2025-12-19","current":25.482373,"twenty":32.772186,"median":49.393282,"eighty":66.988433,"marketCap":520579403},{"date":"2025-12-26","current":25.913613,"twenty":32.474667,"median":46.160548,"eighty":66.182557,"marketCap":529389208},{"date":"2026-01-02","current":24.933522,"twenty":30.002996,"median":45.709762,"eighty":65.94751,"marketCap":509366924},{"date":"2026-01-09","current":25.717595,"twenty":27.520963,"median":45.43929,"eighty":65.757233,"marketCap":525384751},{"date":"2026-01-16","current":24.737504,"twenty":27.019156,"median":45.168818,"eighty":65.594939,"marketCap":505362467},{"date":"2026-01-23","current":24.619893,"twenty":26.909386,"median":44.627874,"eighty":65.546241,"marketCap":502959792},{"date":"2026-01-30","current":23.482987,"twenty":26.540872,"median":44.492638,"eighty":65.122582,"marketCap":479733942},{"date":"2026-02-06","current":20.111473,"twenty":26.282128,"median":44.267244,"eighty":64.478311,"marketCap":410857283},{"date":"2026-02-13","current":19.954658,"twenty":25.944976,"median":44.008043,"eighty":64.391721,"marketCap":407653717},{"date":"2026-02-20","current":19.366604,"twenty":25.843047,"median":43.816458,"eighty":64.134289,"marketCap":395640346},{"date":"2026-02-27","current":20.307491,"twenty":25.623506,"median":43.591065,"eighty":63.1941,"marketCap":414861740},{"date":"2026-03-06","current":23.545172,"twenty":25.529418,"median":43.41075,"eighty":62.988163,"marketCap":409262188},{"date":"2026-03-13","current":22.252496,"twenty":25.411807,"median":43.320593,"eighty":62.862521,"marketCap":386792892},{"date":"2026-03-20","current":21.88316,"twenty":25.058974,"median":43.095199,"eighty":62.753162,"marketCap":380373093},{"date":"2026-03-27","current":20.636651,"twenty":24.761026,"median":42.599334,"eighty":62.487416,"marketCap":358706271},{"date":"2026-04-02","current":20.867486,"twenty":24.619893,"median":42.419019,"eighty":62.007672,"marketCap":362718645},{"date":"2026-04-10","current":20.682818,"twenty":24.345467,"median":42.035851,"eighty":61.696037,"marketCap":359508746},{"date":"2026-04-17","current":21.836993,"twenty":23.875024,"median":35.567063,"eighty":61.604905,"marketCap":379570618},{"date":"2026-04-24","current":21.836993,"twenty":23.545172,"median":34.102007,"eighty":61.448036,"marketCap":379570618},{"date":"2026-05-01","current":21.836993,"twenty":23.175836,"median":33.854074,"eighty":61.280145,"marketCap":379570618},{"date":"2026-05-08","current":18.041368,"twenty":22.760333,"median":33.696298,"eighty":61.168218,"marketCap":336236974},{"date":"2026-05-15","current":16.273169,"twenty":22.34483,"median":33.493445,"eighty":60.552618,"marketCap":303283042},{"date":"2026-05-22","current":16.230344,"twenty":22.248072,"median":33.448366,"eighty":60.552618,"marketCap":302484929},{"date":"2026-05-29","current":16.444465,"twenty":22.012428,"median":33.155355,"eighty":60.44668,"marketCap":306475495},{"date":"2026-06-05","current":14.988445,"twenty":21.873927,"median":32.772186,"eighty":60.257509,"marketCap":279339644},{"date":"2026-06-12","current":14.688676,"twenty":21.735571,"median":32.546792,"eighty":59.723377,"marketCap":273752851},{"date":"2026-06-18","current":14.431731,"twenty":21.468256,"median":32.208703,"eighty":59.545333,"marketCap":268964171},{"date":"2026-06-26","current":14.174786,"twenty":20.98752,"median":28.148222,"eighty":59.396403,"marketCap":264175492},{"date":"2026-07-02","current":14.260435,"twenty":20.867486,"median":27.834592,"eighty":59.097565,"marketCap":265771718},{"date":"2026-07-10","current":14.945621,"twenty":20.636651,"median":27.324945,"eighty":58.568512,"marketCap":278541531},{"date":"2026-07-17","current":14.560203,"twenty":20.370149,"median":27.050519,"eighty":58.147287,"marketCap":271358511},{"date":"2026-07-24","current":13.660897,"twenty":20.127155,"median":26.95251,"eighty":57.524987,"marketCap":254598133},{"date":"2026-07-31","current":14.21761,"twenty":20.033066,"median":26.893705,"eighty":56.881406,"marketCap":264973605},{"date":"2026-08-07","current":15.07415,"twenty":19.767151,"median":26.540872,"eighty":56.825443,"marketCap":241050726},{"date":"2026-08-14","current":15.123736,"twenty":19.424638,"median":26.403659,"eighty":56.657552,"marketCap":241843656},{"date":"2026-08-21","current":15.619596,"twenty":18.243689,"median":26.266446,"eighty":56.409541,"marketCap":249772956},{"date":"2026-08-28","current":15.917112,"twenty":16.632891,"median":26.011623,"eighty":55.822209,"marketCap":254530536},{"date":"2026-09-04","current":15.421252,"twenty":16.410206,"median":25.913613,"eighty":55.269655,"marketCap":246601236},{"date":"2026-09-11","current":15.049357,"twenty":16.273169,"median":25.835206,"eighty":55.180113,"marketCap":240654261},{"date":"2026-09-18","current":14.826219,"twenty":16.059048,"median":25.737197,"eighty":55.043436,"marketCap":237086075},{"date":"2026-09-25","current":14.925392,"twenty":15.844927,"median":25.560781,"eighty":54.815607,"marketCap":238671936},{"date":"2026-10-02","current":13.289053,"twenty":15.716455,"median":25.541179,"eighty":54.452586,"marketCap":212505245},{"date":"2026-10-09","current":13.189881,"twenty":15.520424,"median":25.482373,"eighty":54.228731,"marketCap":210919385}],"updateTime":1791647658771},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAGE\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636181718","title":"Niagen Bioscience Earnings Call Highlights Growth Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2636181718","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636181718?lang=en_us&edition=fundamental","pubTime":"2026-05-20 13:40","pubTimestamp":1779255622,"startTime":"0","endTime":"0","summary":"Niagen Bioscience, Inc. (($NAGE)) has held its Q1 earnings call. Read on for the main highlights of the call. Niagen Bioscience’s latest earnings c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-earnings-call-highlights-growth-push-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-earnings-call-highlights-growth-push-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635896510","title":"Promising Penny Stocks To Consider In May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635896510","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635896510?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:05","pubTimestamp":1778843111,"startTime":"0","endTime":"0","summary":"The United States market has shown impressive growth, with a 1.1% increase over the last week and a substantial 27% rise over the past year, alongside expectations for earnings to grow by 17% annually in the coming years. Penny stocks, while an older term, continue to capture attention as they often represent smaller or newer companies that provide growth opportunities at lower price points. By focusing on those with strong financial health and solid fundamentals, investors can uncover...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ltrn/lantern-pharma/news/promising-penny-stocks-to-consider-in-may-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ltrn/lantern-pharma/news/promising-penny-stocks-to-consider-in-may-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VFF","NAGE","BK4161","BK4006","LU0049112450.USD","BK4526","BK4209","BK4121","BK4579","LU1235295612.USD","FINV","BK4509","BK4183","III","BK4166","BABB","ZJK","LX","BK4189","BK4531","BK4023","LU1046422090.SGD","HLP","TUYA","BK4139","BK4134","SPRO","BK4505","LTRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635871123","title":"May 2026's Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2635871123","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635871123?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:04","pubTimestamp":1778756692,"startTime":"0","endTime":"0","summary":"The market remained flat over the last week but is up 25% over the past year, with earnings forecast to grow by 17% annually. In light of these conditions, identifying stocks with strong financials and clear growth potential becomes crucial for investors seeking value. Although the term \"penny stocks\" may seem outdated, it still points to smaller or less-established companies that can offer significant opportunities; we've identified three such stocks that stand out for their financial...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-whwk/whitehawk-therapeutics/news/may-2026s-promising-penny-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-whwk/whitehawk-therapeutics/news/may-2026s-promising-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BABB","BK4531","BK4189","BK4505","CRCT","LU0049112450.USD","LX","WHWK","NAGE","BK4209","LU1235295612.USD","BK4023","BK4139","ZJK","BK4526","MAPS","BK4539","LU1046422090.SGD","BK4213","BK4579","CRBU","ZNOG","BK4121","BK4183","BK4161","BK4509","BK4191","TUYA","VFF","BK4166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635789270","title":"Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2635789270","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635789270?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:05","pubTimestamp":1778670322,"startTime":"0","endTime":"0","summary":"The market has climbed 1.5% in the last 7 days and is up 26% over the last 12 months, with earnings forecast to grow by 17% annually. While the term 'penny stock' might seem outdated, these investments still offer potential value by focusing on smaller or newer companies with strong financials. In this article, we explore three penny stocks that demonstrate financial strength and could present opportunities for investors seeking hidden value in quality companies.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmci/treace-medical-concepts/news/spotlight-on-oramed-pharmaceuticals-and-two-other-prominent","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmci/treace-medical-concepts/news/spotlight-on-oramed-pharmaceuticals-and-two-other-prominent","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["III","NAGE","WDH","VFF","ZJK","LU0049112450.USD","BK4531","BK4139","BK4173","LU1046422090.SGD","BABB","BK4209","BK4161","BK4183","BK4189","LU1235295612.USD","LX","TMCI","BK4134","CRCT","MGNX","ORMP","BK4509","BK4082","BK4007","BK4121","BK4166","BK4191","BK4579","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213100","title":"Creative Global Technology Holdings And 2 Other Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213100","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634213100?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:04","pubTimestamp":1778583898,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the U.S. market has risen by 2.6%, and in the past year, it has climbed an impressive 26%, with earnings forecasted to grow by 17% annually. In such a robust market environment, identifying stocks with solid financials becomes crucial for investors seeking potential growth opportunities. Though often considered a relic of past trading days, penny stocks still hold relevance today as they offer affordability and growth potential when backed by strong fundamentals; this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4133000-choice2-main-header/1585187156628","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4133000-choice2-main-header/1585187156628"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-durables/nyse-ufi/unifi/news/creative-global-technology-holdings-and-2-other-promising-pe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-durables/nyse-ufi/unifi/news/creative-global-technology-holdings-and-2-other-promising-pe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4134","LX","BK4531","BK4579","BK4161","BK4166","CINT","PYXS","BK4010","BK4140","BK4189","NAGE","MAPS","BK4539","ZJK","BK4173","LU1046422090.SGD","BK4509","VFF","BK4209","LU1235295612.USD","UFI","LU0049112450.USD","BK4023","BK4183","BABB","CGTL","BK4139","WDH","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634283906","title":"Niagen Bioscience Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2634283906","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634283906?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:15","pubTimestamp":1778498100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 07:15 ET (11:15 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633721456","title":"Niagen Bioscience to attend Sohn Investment Conference Emerging Company Pavilion","url":"https://stock-news.laohu8.com/highlight/detail?id=2633721456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633721456?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:32","pubTimestamp":1778243540,"startTime":"0","endTime":"0","summary":"Niagen Bioscience management scheduled to attend two investor conferences in New York in May 2026.Participation set for May 12 at Sohn Investment Conference, with CFO Ozan Pamir representing company.CEO Rob Fried slated to join CFO Ozan Pamir for investor meetings at Benchmark Consumer One-On-One Conference on May 19.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL3xW2y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633302172","title":"The Benchmark Company Announces 4th Annual Consumer One-on-One Conference in New York City","url":"https://stock-news.laohu8.com/highlight/detail?id=2633302172","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633302172?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:10","pubTimestamp":1778184600,"startTime":"0","endTime":"0","summary":"NEW YORK, May  07, 2026 (GLOBE NEWSWIRE) -- The Benchmark Company, a subsidiary of StoneX Group Inc. (“StoneX”; NASDAQ: SNEX), is pleased to announce its 4TH Annual Consumer One-on-One Conference at t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290609/11961/en/The-Benchmark-Company-Announces-4th-Annual-Consumer-One-on-One-Conference-in-New-York-City.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4214","LU1169589451.USD","BK4585","LU0266013472.USD","FWRG","MBUU","LU2065731478.USD","BK4209","BK4211","PAG","LU1878469433.USD","CHEF","LU1815336091.USD","SAH","CHCO","CALM","ONEW","LU1941712264.USD","BK4588","BK4127","BK4121","LU0757428866.USD","DIN","LU1941712348.USD","LU0053671581.USD","LU1169590202.USD","BK4517","KRUS","ANDE","SNEX","BK4142","LU0029874061.USD","BK4183","LU0128526141.USD","FRPT","JJSF","BK4124","NAGE","STKS","WEST","PATK","BK4212","LIND","LU0054578231.USD","LU2065732104.USD","BJRI","BK4102","BK4190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633317128","title":"Niagen Bioscience price target lowered to $12 from $13 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2633317128","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633317128?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:07","pubTimestamp":1778184458,"startTime":"0","endTime":"0","summary":"Roth Capital lowered the firm’s price target on Niagen Bioscience (NAGE) to $12 from $13 and keeps a Buy rating on the shares. The company’s Q1 res...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-price-target-lowered-to-12-from-13-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-price-target-lowered-to-12-from-13-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633667261","title":"Niagen Bioscience posts investor deck outlining NAD+ healthy-aging strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2633667261","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633667261?lang=en_us&edition=fundamental","pubTime":"2026-05-07 07:39","pubTimestamp":1778110749,"startTime":"0","endTime":"0","summary":"Niagen Bioscience investor presentation outlined strategy to expand NAD+ franchise across consumer supplements, IV therapies, injections, skincare.Q1 2026 LTM metrics showed USD 130.4 million revenue, USD 18.6 million net income, USD 66.5 million cash, no debt.Niagen IV and injectables push targeted NAD+ IV market sized at about USD 300 million, positioned as faster to administer with fewer side effects versus NAD+ IV.Early traction cited for Niagen IV, including more than 1,500 clinics onboarded since August 2024, USD 6.4 million ingredient sales since launch.Product development highlighted Niagen NanoCloud topical format, positioned as waterless delivery to reduce degradation risk seen in water-based NAD+ skincare.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL9QdTdZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633168760","title":"Niagen Bioscience Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633168760","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633168760?lang=en_us&edition=fundamental","pubTime":"2026-05-07 05:39","pubTimestamp":1778103551,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc reports results for the quarter ended March 31 - Earnings SummaryNiagen Bioscience Inc NAGE.OQ reported quarterly adjusted earnings of 7 cents per share for the quarter ended Mar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL8N41J3O6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633590461","title":"Niagen Bioscience Keeps Full-Year Sales Forecast Intact As Q1 Revenue, Profit Climbs","url":"https://stock-news.laohu8.com/highlight/detail?id=2633590461","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633590461?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:07","pubTimestamp":1778098038,"startTime":"0","endTime":"0","summary":"Niagen Bioscience reaffirms 2026 sales outlook after first-quarter revenue and profit rose alongside investments in injections and skincare.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/biotech/26/05/52342938/niagen-bioscience-keeps-full-year-sales-forecast-intact-as-q1-revenue-profit-climbs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633159984","title":"BRIEF-Niagen Bioscience Inc Q1 Sales USD 31.474 Million Vs. IBES Estimate USD 30.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633159984","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633159984?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:02","pubTimestamp":1778097765,"startTime":"0","endTime":"0","summary":"BRIEF-Niagen Bioscience Inc Q1 Sales USD 31.474 Million Vs. IBES Estimate USD 30.9 Million\n\n\nMay 06 (Reuters) - Niagen Bioscience Inc Q1 net income USD 6.318 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX9FE0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","NAGE","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633154911","title":"Niagen Bioscience Inc Outlook FY Revenue Growth 10-15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633154911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633154911?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:02","pubTimestamp":1778097721,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX9FE0E2:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633153159","title":"Niagen Bioscience Inc Q1 EPS USD 0.07 VS. Ibes Estimate USD 0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2633153159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633153159?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:02","pubTimestamp":1778097721,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX9FE0E2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633159904","title":"Press Release: Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633159904","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633159904?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:02","pubTimestamp":1778097720,"startTime":"0","endTime":"0","summary":"Net income of $6.3 million, up $1.3 million from the prior year and adjusted EBITDA of $3.8 million. Niagen Bioscience, Inc.  today announced financial results for the first quarter of 2026.--  Total net sales increased 3% to $31.5 million, including $22.4 million. from Tru Niagen. Excluding the recently sold Analytical Reference. Standards and Services segment from both periods, net sales rose 5% to. --  Gross margin of 63.5%, reflecting continued strength in business mix.divestiture of the Analytical Reference Standards and Services operating. --  Basic and diluted earnings per share were $0.08 and $0.07,--  Working capital increased by $5.4 million quarter-over-quarter.increased inventory levels and timing of receivables, ending with $66.5. to increase; general & administrative expense outlook improved to up. --  In May 2026, the Company launched a clinician-directed telehealth. platform under Niagen Plus, enabling eligible U.S. patients to access. --  In April 2026, the Company ann","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4022","BK4183","BK4121","NAGE","R","03160","BK4099","BK4585","BK4555","BK4604","BK4588","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633928746","title":"Niagen Bioscience Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2633928746","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633928746?lang=en_us&edition=fundamental","pubTime":"2026-05-06 02:59","pubTimestamp":1778007540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2026 14:59 ET (18:59 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633142964","title":"Niagen Bioscience Inc  expected to post earnings of 8 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633142964","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633142964?lang=en_us&edition=fundamental","pubTime":"2026-05-05 06:03","pubTimestamp":1777932185,"startTime":"0","endTime":"0","summary":"Niagen Bioscience Inc  expected to post earnings of8cents a share - Earnings Preview Niagen Bioscience Inc NAGE.OQ NAGE.O is expected to  show a rise in quarterly revenue when it reports  results on M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H2KG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632953126","title":"BRIEF-Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2632953126","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632953126?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:35","pubTimestamp":1777898129,"startTime":"0","endTime":"0","summary":"BRIEF-Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit OfferingMay 4 (Reuters) - Niagen Bioscience Inc NAGE.O:NIAGEN BIOSCIENCE LAUNCHES NIAGEN PLUS TELEHEAL","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA1F1LR1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632265018","title":"3 Promising Penny Stocks With Market Caps Under $200M","url":"https://stock-news.laohu8.com/highlight/detail?id=2632265018","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632265018?lang=en_us&edition=fundamental","pubTime":"2026-05-01 01:05","pubTimestamp":1777568718,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the market has remained flat, yet it is up 28% over the past year with earnings forecasted to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for growth at lower price points, especially when backed by strong balance sheets and solid fundamentals. This article explores several penny stocks that stand out as hidden gems, potentially offering both stability and upside in today's market landscape.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nysemkt-xtnt/xtant-medical-holdings/news/3-promising-penny-stocks-with-market-caps-under-200m-9","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nysemkt-xtnt/xtant-medical-holdings/news/3-promising-penny-stocks-with-market-caps-under-200m-9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NAGE","FINV","BK4189","LX","BK4198","LU1235295612.USD","NEPH","BK4183","BK4583","SIGA","BK4191","RGP","BK4539","BABB","CRCT","VFF","BK4007","BK4166","BK4579","LU0049112450.USD","BK4121","III","BK4023","BK4161","MAPS","BK4123","XTNT","LU1046422090.SGD","BK4209","BK4531","BK4134"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":89,"code":"91000000","status":"200"}]}}